Sayna Norouzi

Sayna Norouzi, MD is an Associate Professor in the Department of Medicine at Loma Linda University School of Medicine. She is a prominent researcher in nephrology with a specialized focus on glomerular diseases, polycystic kidney disease, lupus nephritis, and IgA nephropathy. Her research spans clinical trials, patient-physician communication, and innovative approaches to disease management.

Dr. Norouzi's research interests encompass a wide range of nephrology topics with particular emphasis on glomerular diseases, autosomal dominant polycystic kidney disease, and lupus nephritis. Her work bridges clinical practice with innovative approaches including artificial intelligence applications in nephrology. She has developed significant expertise in cardiovascular complications of kidney diseases and patient-centered communication strategies for those with advanced kidney conditions.

Her publication trends reveal a strong focus on systematic reviews, clinical guidelines, and innovative approaches to kidney disease management. Recent work demonstrates growing interest in artificial intelligence applications for clinical trials, comprehensive management of lupus nephritis, and vascular access care evolution. She has been particularly active in organizing and reporting on international conferences related to glomerular diseases.

Dr. Norouzi has received significant recognition through multiple research grants as Principal Investigator from organizations including GlomCon, Otsuka Pharmaceuticals, and the Loma Linda University Department of Medicine. Her funded projects address critical gaps in understanding health-related quality of life in specific kidney conditions, multi-site disease registries, and innovative clinical trials for IgA nephropathy.

She actively mentors junior researchers and leads multiple collaborative projects investigating kidney disease manifestations, cardiovascular risk management, and innovative educational approaches including AI-powered education for rare kidney diseases. Her leadership extends to developing international registries and organizing major conferences in glomerular diseases.